| Cited nodes | Nodes / Authors | GCS | LCS |
| 1 | 1 2000 CHEMISTRY & INDUSTRY (19):623-623
[Anon]
Designer medicine works for asthmatics | 0 | 0
|
| 1 | 2 2000 DRUG DISCOVERY TODAY 5(12):547-553
Drews J
Quo vadis, biotech? (Part 1) | 5 | 0
|
| 0 | 3 2000 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 97(19):10483-10488
Drysdale CM; McGraw DW; Stack CB; Stephens JC; Judson RS; Nandabalan K; Arnold K; Ruano G; Liggett SB
Complex promoter and coding region beta(2)-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness | 86 | 86
|
| 1 | 4 2000 TRENDS IN PHARMACOLOGICAL SCIENCES 21(12):461-461
McCarthy J
The true nature of pharmacogenomic associations? | 0 | 0
|
| 1 | 5 2001 AAPS PHARMSCI 3(3):art. no.-22
Sadee W; Hoeg E; Lucas J; Wang DX
Genetic variations in human G protein-coupled receptors: Implications for drug therapy | 0 | 0
|
| 1 | 6 2001 AAPS PHARMSCI 3(3):U27-U29
Schubbert S
Genotyping and drug response: Use of single nucleotide polymorphisms (SNPs) versus haplotypes to predict albuterol efficacy | 0 | 0
|
| 1 | 7 2001 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 163(6):1404-1409
Wang ZX; Chen CZ; Niu TH; Wu D; Yang JH; Wang BY; Fang Z; Yandava CN; Drazen JM; Weiss ST; Xu XP
Association of asthma with beta(2)-adrenergic receptor gene polymorphism and cigarette smoking | 6 | 1
|
| 2 | 8 2001 ANNALS OF MEDICINE 33(8):542-546
Arner P
Genetic variance and lipolysis regulation: implications for obesity | 1 | 0
|
| 1 | 9 2001 ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS 2():1-8
Ruddle F
Hundred-year search for the human genome | 0 | 0
|
| 2 | 10 2001 ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS 2():9-39
Evans WE; Johnson JA
Pharmacogenomics: The inherited basis for interindividual differences in drug response | 7 | 1
|
| 1 | 11 2001 ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 41():101-121
McLeod HL; Evans WE
Pharmacogenomics: Unlocking the human genome for better drug therapy | 22 | 1
|
| 1 | 12 2001 ARTHRITIS RESEARCH 3(4):216-220
John S; Worthington J
Genetic epidemiology - Approaches to the genetic analysis of rheumatoid arthritis | 0 | 0
|
| 1 | 13 2001 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 52(5):489-499
Daly AK; Day CP
Candidate gene case-control association studies: advantages and potential pitfalls | 2 | 0
|
| 1 | 14 2001 CARDIOVASCULAR RESEARCH 52(3):345-360
Carmeliet E; Fozzard HA; Hiraoka M; Janse MJ; Ogawa S; Roden DM; Rosen MR; Rudy Y; Schwartz PJ; Matteo PS; Antzelevitch C; Boyden PA; Catterall WA; Fishman GI; George AL; Izumo S; Jalife J; January CT; Kleber AG; Marban E; Marks AR; Spooner PM; Waldo AL; Weiss JM; Zipes DP
New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias | 0 | 0
|
| 1 | 15 2001 CIRCULATION 103(8):1042-1043
Feldman RD
Adrenergic receptor polymorphisms and cardiac function (and dysfunction) - A failure to communicate? | 1 | 0
|
| 1 | 16 2001 CIRCULATION 103(12):1608-1610
Roden DM; Brown NJ
Preprescription genotyping - Not yet ready for prime time, but getting there | 7 | 0
|
| 1 | 17 2001 CIRCULATION 104(23):2865-2873
Carmeliet E; Fozzard HA; Hiraoka M; Janse MJ; Ogawa S; Roden DM; Rosen MR; Rudy Y; Schwartz PJ; Matteo PS; Antzelevitch C; Boyden PA; Catterall WA; Fishman GI; George AL; Izumo S; Jalife J; January CT; Kleber AG; Marban E; Marks AR; Spooner PM; Waldo AL; Weiss JM; Zipes DLP
New approaches to antiarrhythmic therapy, part I - Emerging therapeutic applications of the cell biology of cardiac arrhythmias | 0 | 0
|
| 1 | 18 2001 CIRCULATION RESEARCH 88(3):253-255
Lenfant C
Cardiovascular research - A look into tomorrow | 0 | 0
|
| 1 | 19 2001 CLINICA CHIMICA ACTA 314(1-2):85-91
Iwamoto N; Ogawa Y; Kajihara S; Hisatomi A; Yasutake T; Yoshimura T; Mizuta T; Hara T; Ozaki I; Yamamoto K
Gln27Glu beta 2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver | 0 | 0
|
| 1 | 20 2001 CURRENT OPINION IN CHEMICAL BIOLOGY 5(1):78-85
Carlson CS; Newman TL; Nickerson DA
SNPing in the human genome | 6 | 2
|
| 5 | 21 2001 CURRENT OPINION IN MOLECULAR THERAPEUTICS 3(6):554-566
Raby BA; Weiss ST
beta(2)-adrenergic receptor genetics | 0 | 0
|
| 1 | 22 2001 CYTOGENETICS AND CELL GENETICS 93(1-2):11-15
Langer S; Jentsch I; Gangnus R; Yan H; Lengauer C; Speicher MR
Facilitating haplotype analysis by fully automated analysis of all chromosomes in human-mouse hybrid cell lines | 1 | 0
|
| 1 | 23 2001 DRUG DISCOVERY TODAY 6(6):316-323
Sanseau P
Impact of human genome sequencing for in silico target discovery | 5 | 0
|
| 1 | 24 2001 DRUG DISCOVERY TODAY 6(10):495-498
Peet NP; Bey P
Pharmacogenomics: challenges and opportunities | 2 | 1
|
| 1 | 25 2001 ENVIRONMENTAL AND MOLECULAR MUTAGENESIS 37(3):179-184
Weber WW
Effect of pharmacogenetics on medicine | 2 | 0
|
| 1 | 26 2001 EUROPEAN HEART JOURNAL 22(23):2148-2163
Schneider E; Knoll AG; Carmeliet E; Fozzard HA; Hiraoka M; Janse J; Ogawa S; Roden DM; Rosen MR; Rudy Y; Schwartz PJ; Matteo S; Camm AJ; Antzelevitch C; Boyden PA; Catterall WA; Fishman GI; George AL; Izumo S; Jalife J; January CT; Kleber AG; Marban E; Marks AR; Spooner PM; Waldo AL; Weiss JM; Zipes DP
New approaches to antiarrhythmic therapy - Emerging therapeutic applications of the cell biology of cardiac arrhythmias | 0 | 0
|
| 1 | 27 2001 EUROPEAN JOURNAL OF PHARMACOLOGY 421(3):141-147
Green SA; Rathz DA; Schuster AJ; Liggett SB
The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s) | 3 | 2
|
| 1 | 28 2001 HUMAN GENETICS 109(6):623-627
Pulleyn LJ; Newton R; Adcock IM; Barnes PJ
TGF beta 1 allele association with asthma severity | 0 | 0
|
| 1 | 29 2001 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 8(2):205-209
Tan Z; Jiang SS; Lin ZX; Zhang BF; Yu J; Feng GY; He L
Identification of SNPs in human gamma aminobutyric acid A receptor gamma 2 gene | 0 | 0
|
| 1 | 30 2001 JOURNAL OF IMMUNOLOGY 167(10):5838-5844
LeVan TD; Bloom JW; Bailey TJ; Karp CL; Halonen M; Martinez FD; Vercelli D
A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity | 2 | 1
|
| 1 | 31 2001 JOURNAL OF INTERNAL MEDICINE 250(3):186-200
Ingelman-Sundberg M
Pharmaco genetics: an opportunity for a safer and more efficient pharmacotherapy | 4 | 0
|
| 1 | 32 2001 JOURNAL OF MOLECULAR BIOLOGY 307(2):683-706
Chasman D; Adams RM
Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: Structure-based assessment of amino acid variation | 10 | 3
|
| 1 | 33 2001 MOLECULAR AND BIOCHEMICAL PARASITOLOGY 118(2):155-165
Brizuela L; Braun P; LaBaer J
FLEXGene repository: from sequenced genomes to gene repositories for high-throughput functional biology and proteomics | 2 | 0
|
| 1 | 34 2001 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 479(1-2):1-18
Weber WW
The legacy of pharmacogenetics and potential applications | 0 | 0
|
| 1 | 35 2001 NATURE BIOTECHNOLOGY 19(3):209-211
Rothberg BEG
Mapping a role for SNPs in drug development | 2 | 1
|
| 1 | 36 2001 NATURE GENETICS 27(2):215-217
Joosten PHLJ; Toepoel M; Mariman ECM; Van Zoelen EJJ
Promoter haplotype combinations of the platelet-derived growth factor alpha-receptor gene predispose to human neural tube defects | 10 | 3
|
| 2 | 37 2001 NATURE GENETICS 29(2):229-232
Daly MJ; Rioux JD; Schaffner SE; Hudson TJ; Lander ES
High-resolution haplotype structure in the human genome | 49 | 3
|
| 2 | 38 2001 NATURE GENETICS 29(2):233-237
Johnson GCL; Esposito L; Barratt BJ; Smith AN; Heward J; Di Genova G; Ueda H; Cordell HJ; Eaves IA; Dudbridge F; Twells RCJ; Payne F; Hughes W; Nutland S; Stevens H; Carr P; Tuomilehto-Wolf E; Tuomilehto J; Gough SCL; Clayton DG; Todd JA
Haplotype tagging for the identification of common disease genes | 29 | 2
|
| 1 | 39 2001 NATURE MEDICINE 7(3):281-283
Liggett SB
Pharmacogenetic applications of the Human Genome Project | 6 | 0
|
| 1 | 40 2001 NEW ENGLAND JOURNAL OF MEDICINE 345(14):1030-1035
Dishy V; Sofowora GG; Xie HG; Kim RB; Byrne DW; Stein CM; Wood AJJ
The effect of common polymorphisms of the beta(2)-adrenergic receptor on agonist-mediated vascular desensitization | 7 | 3
|
| 1 | 41 2001 PHARMACOGENETICS 11(3):187-189
Hein L
Physiological significance of beta-adrenergic receptor polymorphisms: in-vivo or in-vitro veritas? | 0 | 0
|
| 2 | 42 2001 PHARMACOGENETICS 11(9):745-746
Evans WE; Ingelman-Sundberg M
Resequencing the sulfotransferase SULT1 gene provides new insights, while illuminating challenges that lie ahead for pharmacogenomics | 0 | 0
|
| 1 | 43 2001 PHARMACOGENETICS 11(9):747-756
Freimuth RR; Eckloff B; Wieben ED; Weinshilboum RM
Human sulfotransferase SULT1C1 pharmacogenetics: gene resequencing and functional genomic studies | 3 | 1
|
| 2 | 44 2001 PHARMACOGENOMICS 2(1):7-10
Judson R; Stephens JC
Notes from the SNP vs. haplotype front | 2 | 1
|
| 1 | 45 2001 PHARMACOGENOMICS 2(1):11-24
Bader JS
The relative power of SNPs and haplotype as genetic markers for association tests | 5 | 1
|
| 1 | 46 2001 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98(24):13757-13762
Posada D; Crandall KA
Evaluation of methods for detecting recombination from DNA sequences: Computer simulations | 1 | 0
|
| 1 | 47 2001 RESPIRATORY RESEARCH 3(1):art. no.-10
Hall IP
Pharmacogenetics, pharmacogenomics and airway disease | 0 | 0
|
| 1 | 48 2001 RESPIRATORY RESEARCH 3(1):art. no.-7
Sengler C; Lau S; Wahn U; Nickel R
Interactions between genes and environmental factors in asthma and atopy: new developments | 0 | 0
|
| 1 | 49 2001 SCIENCE 293(5529):489-493
Stephens JC; Schneider JA; Tanguay DA; Choi J; Acharya T; Stanley SE; Jiang RH; Messer CJ; Chew A; Han JH; Duan JC; Carr JL; Lee MS; Koshy B; Kumar AM; Zhang G; Newell WR; Windemuth A; Xu CB; Kalbfleisch TS; Shaner SL; Arnold K; Schulz V; Drysdale CM; Nandabalan K; Judson RS; Ruano G; Vovis GF
Haplotype variation and linkage disequilibrium in 313 human genes | 45 | 13
|
| 1 | 50 2001 SCIENTIST 15(12):10-+
Wallace J
Personalized prescribing | 2 | 0
|
| 1 | 51 2001 TRENDS IN BIOTECHNOLOGY 19(2):40-41
McCarthy JJ
The true nature of pharmacogenomic associations? | 0 | 0
|
| 1 | 52 2002 ALLERGOLOGIE 25(2):52-65
Sengler C; Nickel R
Genetics of asthma and atopic dermatitis | 0 | 0
|
| 4 | 53 2002 AMERICAN JOURNAL OF HUMAN GENETICS 70(1):157-169
Niu TH; Qin ZHS; Xu XP; Liu JS
Bayesian haplotype inference for multiple linked single- nucleotide polymorphisms | 3 | 0
|
| 1 | 54 2002 AMERICAN JOURNAL OF HUMAN GENETICS 70(1):230-236
Howard TD; Koppelman GH; Xu JF; Zheng SQL; Postma DS; Meyers DA; Bleecker ER
Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma | 3 | 0
|
| 2 | 55 2002 AMERICAN JOURNAL OF HUMAN GENETICS 70(2):425-434
Schaid DJ; Rowland CM; Tines DE; Jacobson RM; Poland GA
Score tests for association between traits and haplotypes when linkage phase is ambiguous | 0 | 0
|
| 1 | 56 2002 AMERICAN JOURNAL OF HUMAN GENETICS 70(5):1152-1171
Herrnstadt C; Elson JL; Fahy E; Preston G; Turnbull DM; Anderson C; Ghosh SS; Olefsky JM; Beal MF; Davis RE; Howell N
Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups | 1 | 0
|
| 1 | 57 2002 AMERICAN JOURNAL OF HUMAN GENETICS 70(5):1257-1268
Xiong MM; Zhao JY; Boerwinkle E
Generalized T-2 test for genome association studies | 0 | 0
|
| 1 | 58 2002 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 165(7):861-866
Palmer LJ; Silverman ES; Weiss ST; Drazen JM
Pharmacogenetics of asthma | 0 | 0
|
| 1 | 59 2002 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 165(10):1353-1358
Hanania NA; Sharfkhaneh A; Barber R; Dickey BF
beta-agonist intrinsic efficacy - Measurement and clinical significance | 0 | 0
|
| 2 | 60 2002 ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 22(5):E1-E4
Wang R; Dudley D; Wang XL
Haplotype-specific effects on endothelial NO synthase promoter efficiency - Modifiable by cigarette smoking | 0 | 0
|
| 1 | 61 2002 BRAIN RESEARCH 926(1-2):1-9
Germeyer S; Birke A; Schmitt U; Dahmen N; Hiemke C; Havemann-Reinecke U
New dopamine D2 receptor polymorphisms in rats and association with apomorphine-induced stereotypies | 0 | 0
|
| 1 | 62 2002 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 53(1):3-15
Fenech A; Hall IP
Pharmacogenetics of asthma | 0 | 0
|
| 2 | 63 2002 CURRENT OPINION IN CHEMICAL BIOLOGY 6(1):24-30
Remm M; Metspalu A
High-density genotyping and linkage disequilibrium in the human genome using chromosome 22 as a model | 1 | 0
|
| 2 | 64 2002 CURRENT OPINION IN CHEMICAL BIOLOGY 6(4):434-438
Meyer JM; Ginsburg GS
The path to personalized medicine | 0 | 0
|
| 1 | 65 2002 EUROPEAN JOURNAL OF PHARMACOLOGY 445(1-2):1-12
Waldeck B
beta-adrenoceptor agonists and asthma - 100 years of development | 0 | 0
|
| 3 | 66 2002 FEBS LETTERS 516(1-3):253-256
Small KM; Seman CA; Castator A; Brown KM; Liggett SB
False positive non-synonymous polymorphisms G-protein coupled receptor genes | 0 | 0
|
| 2 | 67 2002 HUMAN HEREDITY 53(2):79-91
Zaykin DV; Westfall PH; Young SS; Karnoub MA; Wagner MJ; Ehm MG
Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals | 0 | 0
|
| 1 | 68 2002 IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA 22(2):223-+
Hjoberg J; Drazen JM; Palmer LJ; Weiss ST; Silverman ES
The pharmacogenetics of asthma and allergic disease | 0 | 0
|
| 2 | 69 2002 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 109(1):14-21
Vercelli D
The functional genomics of CD14 and its role in IgE responses: An integrated view | 0 | 0
|
| 1 | 70 2002 JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY 13(3):252-256
Kanki H; Yang P; Xie HG; Kim RB; George AL; Roden DM
Polymorphisms in beta-adrenergic receptor genes in the acquired long QT syndrome | 0 | 0
|
| 1 | 71 2002 JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 87(6):2495-2499
Hockett RD; Kirkwood SC; Mitlak BH; Dere WH
Pharmacogemomics in endocrinology | 0 | 0
|
| 1 | 72 2002 MAMMALIAN GENOME 13(4):211-215
Stone RT; Grosse WM; Casas E; Smith TPL; Keele JW; Bennett GL
Use of bovine EST data and human genomic sequences to map 100 gene-specific bovine markers | 0 | 0
|
| 3 | 73 2002 NATURE REVIEWS GENETICS 3(5):391-A396
Tabor HK; Risch NJ; Myers RM
Candidate-gene approaches for studying complex genetic traits: practical considerations | 0 | 0
|
| 1 | 74 2002 NEUROPSYCHOPHARMACOLOGY 27(1):105-119
Lerer B; Segman RH; Fangerau H; Daly AK; Basile VS; Cavallaro R; Aschauer HN; McCreadie RG; Ohlraun S; Ferrier N; Masellis M; Verga M; Scharfetter J; Rietschel M; Lovlie R; Levy UH; Meltzer HY; Kennedy JL; Steen VM; Macciardi F
Pharmacogenetics of tardive dyskinesia: Combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism | 0 | 0
|
| 1 | 75 2002 NUCLEIC ACIDS RESEARCH 30(2):art. no.-e10
Benters R; Niemeyer CM; Drutschmann D; Blohm D; Wohrle D
DNA microarrays with PAMAM dendritic linker systems | 0 | 0
|
| 5 | 76 2002 PHARMACOGENETICS 12(2):89-90
Nothen MM; Cichon S
Linking single nucleotide polymorphisms | 1 | 0
|
| 3 | 77 2002 PHARMACOGENETICS 12(2):93-99
McDonald OG; Krynetski EY; Evans WE
Molecular haplotyping of genomic DNA for multiple single- nucleotide polymorphisms located kilobases apart using long- range polymerase chain reaction and intramolecular ligation | 2 | 1
|
| 1 | 78 2002 PHARMACOGENETICS 12(2):121-132
Lamba JK; Lin YS; Thummel K; Daly A; Watkins PB; Strom S; Zhang J; Schuetz EG
Common allelic variants of cytochrome P4503A4 and their prevalence in different populations | 2 | 0
|
| 2 | 79 2002 PHARMACOGENOMICS 3(1):47-56
Ring HZ; Kroetz DL
Candidate gene approach for pharmacogenetic studies | 0 | 0
|
| 4 | 80 2002 PHARMACOGENOMICS 3(2):173-184
Taylor DR; Kennedy MA
Beta-adrenergic receptor polymorphisms and drug responses in asthma | 0 | 0
|
| 2 | 81 2002 PHARMACOGENOMICS 3(2):257-263
Pettipher R; Cardon LR
The application of genetics to the discovery of better medicines | 0 | 0
|
| 2 | 82 2002 PHARMACOGENOMICS 3(2):273-279
Oestreicher P
Genaissance Pharmaceuticals, Inc. | 0 | 0
|
| 3 | 83 2002 PHARMACOGENOMICS 3(3):393-402
Balasubramanian S; Harrison P; Hegyi H; Bertone P; Luscombe N; Echols N; McGarvey P; Zhang ZL; Gerstein M
SNPs on human chromosomes 21 and 22 - analysis in terms of protein features and pseudogenes | 0 | 0
|
| 4 | 84 2002 PHARMACOGENOMICS 3(4):453-467
Ferentz AE
Integrating pharmacogenomics into drug development | 0 | 0
|
| 2 | 85 2002 PSYCHIATRIC GENETICS 12(2):89-96
Athanasiou MC; Malhotra AK; Xu CB; Stephens JC
Discovery and utilization of haplotypes for pharmacogenetic studies of psychotropic drug response | 0 | 0
|
| 1 | 86 2002 THORAX 57(1):61-66
Lipworth B; Koppelman GH; Wheatley AP; Le Jeune I; Coutie W; Meurs H; Kauffman HF; Postma DS; Hall IP
beta(2) adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells | 1 | 1
|
| 2 | 87 2002 TRENDS IN GENETICS ():S2-S9
Carlson CS; Newman TL; Nickerson DA
SNPing in the human genome (Reprinted from Current Opinion Chemical Biology, vol 5, pg 78-85, 2001) | 0 | 0
|